Literature DB >> 15608616

Abl-kinase-sensitive levels of ERK5 and its intrinsic basal activity contribute to leukaemia cell survival.

Marcus Buschbeck1, Sebastian Hofbauer, Luciano Di Croce, Gyorgy Keri, Axel Ullrich.   

Abstract

It is well established that the mitogen-activated protein kinase (MAPK) signal is regulated through phosphorylation-dependent activation by the three-tiered MAPK cascade. However, our studies on the interaction of the MAPK ERK5 with the tyrosine kinase c-Abl and its oncogenic variants v-Abl and Bcr/Abl disclosed an alternative aspect of regulation. Independent of the MAPK cascade, Abl kinases were able to regulate the cellular amount of ERK5, at least in part, by stabilizing the protein. The resulting level of ERK5 and its intrinsic basal activity, but not necessarily its activation, were essential and sufficient to increase transformation by v-Abl and to mediate survival of Bcr/Abl-expressing leukaemia cells. These results suggest that the ability to regulate the cellular abundance of ERK5 contributes to the oncogenic potential of Abl kinases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15608616      PMCID: PMC1299226          DOI: 10.1038/sj.embor.7400316

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  19 in total

Review 1.  Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals.

Authors:  B A Ballif; J Blenis
Journal:  Cell Growth Differ       Date:  2001-08

2.  The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2.

Authors:  Zhimin Lu; Shuichan Xu; Claudio Joazeiro; Melanie H Cobb; Tony Hunter
Journal:  Mol Cell       Date:  2002-05       Impact factor: 17.970

3.  Phosphotyrosine-specific phosphatase PTP-SL regulates the ERK5 signaling pathway.

Authors:  Marcus Buschbeck; Jan Eickhoff; Marc N Sommer; Axel Ullrich
Journal:  J Biol Chem       Date:  2002-05-31       Impact factor: 5.157

4.  Granulocyte colony-stimulating factor induces ERK5 activation, which is differentially regulated by protein-tyrosine kinases and protein kinase C. Regulation of cell proliferation and survival.

Authors:  F Dong; J S Gutkind; A C Larner
Journal:  J Biol Chem       Date:  2001-01-17       Impact factor: 5.157

5.  Reversibility of acute B-cell leukaemia induced by BCR-ABL1.

Authors:  C S Huettner; P Zhang; R A Van Etten; D G Tenen
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

6.  Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway.

Authors:  N Mody; J Leitch; C Armstrong; J Dixon; P Cohen
Journal:  FEBS Lett       Date:  2001-07-27       Impact factor: 4.124

7.  Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.

Authors:  Chunrong Yu; Geoffrey Krystal; Lyuba Varticovksi; Robert McKinstry; Mohamed Rahmani; Paul Dent; Steven Grant
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

8.  Neurotrophins use the Erk5 pathway to mediate a retrograde survival response.

Authors:  F L Watson; H M Heerssen; A Bhattacharyya; L Klesse; M Z Lin; R A Segal
Journal:  Nat Neurosci       Date:  2001-10       Impact factor: 24.884

Review 9.  Multifaceted approach to the treatment of bcr-abl-positive leukemias.

Authors:  Michael O'Dwyer
Journal:  Oncologist       Date:  2002

10.  Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor.

Authors:  Y Kato; R I Tapping; S Huang; M H Watson; R J Ulevitch; J D Lee
Journal:  Nature       Date:  1998-10-15       Impact factor: 49.962

View more
  10 in total

1.  The histone variant macroH2A is an epigenetic regulator of key developmental genes.

Authors:  Marcus Buschbeck; Iris Uribesalgo; Indra Wibowo; Pau Rué; David Martin; Arantxa Gutierrez; Lluís Morey; Roderic Guigó; Hernán López-Schier; Luciano Di Croce
Journal:  Nat Struct Mol Biol       Date:  2009-09-06       Impact factor: 15.369

2.  Inhibition of ERK5 enhances cytarabine-induced apoptosis in acute myeloid leukemia cells.

Authors:  Yu Xu; Cuiming Cao; Xiuchun Gong; LiJun Rong
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  MacroH2A1 regulates the balance between self-renewal and differentiation commitment in embryonic and adult stem cells.

Authors:  Catherine Creppe; Peggy Janich; Neus Cantariño; Marc Noguera; Vanesa Valero; Eva Musulén; Julien Douet; Melanija Posavec; Juan Martín-Caballero; Lauro Sumoy; Luciano Di Croce; Salvador A Benitah; Marcus Buschbeck
Journal:  Mol Cell Biol       Date:  2012-02-13       Impact factor: 4.272

4.  ERK2, but not ERK1, mediates acquired and "de novo" resistance to imatinib mesylate: implication for CML therapy.

Authors:  Clara I Aceves-Luquero; Anupriya Agarwal; Juan L Callejas-Valera; Laura Arias-González; Azucena Esparís-Ogando; Luis del Peso Ovalle; Itxaso Bellón-Echeverria; Miguel A de la Cruz-Morcillo; Eva M Galán Moya; Inmaculada Moreno Gimeno; Juan C Gómez; Michael W Deininger; Atanasio Pandiella; Ricardo Sánchez Prieto
Journal:  PLoS One       Date:  2009-07-01       Impact factor: 3.240

5.  MEK5 and ERK5 are mediators of the pro-myogenic actions of IGF-2.

Authors:  Emma J Carter; Ruth A Cosgrove; Ivelisse Gonzalez; Joan H Eisemann; Fiona A Lovett; Laura J Cobb; Jennifer M Pell
Journal:  J Cell Sci       Date:  2009-08-04       Impact factor: 5.285

6.  ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma.

Authors:  Laura Arias-González; Inmaculada Moreno-Gimeno; Antonio Rubio del Campo; Leticia Serrano-Oviedo; María Llanos Valero; Azucena Esparís-Ogando; Miguel Ángel de la Cruz-Morcillo; Pedro Melgar-Rojas; Jesús García-Cano; Francisco José Cimas; María José Ruiz Hidalgo; Alfonso Prado; Juan Luis Callejas-Valera; Syong Hyun Nam-Cha; José Miguel Giménez-Bachs; Antonio S Salinas-Sánchez; Atanasio Pandiella; Luis del Peso; Ricardo Sánchez-Prieto
Journal:  Neoplasia       Date:  2013-06       Impact factor: 5.715

7.  ERK5 pathway regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells.

Authors:  Xuening Wang; Stella Pesakhov; Jonathan S Harrison; Michael Danilenko; George P Studzinski
Journal:  J Cell Physiol       Date:  2014-07       Impact factor: 6.384

8.  Murine cell glycolipids customization by modular expression of glycosyltransferases.

Authors:  Emili Cid; Miyako Yamamoto; Marcus Buschbeck; Fumiichiro Yamamoto
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

9.  Multiple signaling pathways regulate the transcriptional activity of the orphan nuclear receptor NURR1.

Authors:  Paola Sacchetti; Rodolphe Carpentier; Pascaline Ségard; Cécile Olivé-Cren; Philippe Lefebvre
Journal:  Nucleic Acids Res       Date:  2006-10-04       Impact factor: 16.971

10.  Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells.

Authors:  Ignazia Tusa; Giulia Cheloni; Martina Poteti; Antonella Gozzini; Ngoc Ho DeSouza; Yi Shan; Xianming Deng; Nathanael S Gray; Shaoguang Li; Elisabetta Rovida; Persio Dello Sbarba
Journal:  Stem Cell Reports       Date:  2018-09-20       Impact factor: 7.765

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.